Breaking News Instant updates and real-time market news.

ABBV

AbbVie

$94.29

-1.08 (-1.13%)

14:29
09/18/18
09/18
14:29
09/18/18
14:29

Citron reiterates $60 AbbVie target, says lawsuit 'least of the problems'

Citron Research just tweeted, "$abbv being sued today by California for price collusion. This the least of the problems. Wait until the government starts exploring the rapid and unjustifiable death rate from Humira tgt $60." Shares of AbbVie are down 2.5% to $92.97 in afternoon trading.

ABBV AbbVie
$94.29

-1.08 (-1.13%)

08/08/18
HCWC
08/08/18
NO CHANGE
Target $44
HCWC
Buy
ObsEva price target raised to $44 from $30 at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju raised his price target for ObsEva (OBSV) to $44 based on the disclosed pricing for AbbVie's (ABBV) Orilissa, the fgonadotropin-releasing hormone receptor antagonist for endometriosis and uterine fibroids. ObsEva management had previously guided to the cost of GnRH receptor antagonist therapy at $15 per day, about $450 per month, and the proposed monthly cost of Orilissa at $845 "appears to be comfortably above this level," Selvaraju tells investors in a research note. As such, the analyst elected to revise his pricing assumptions upward for ObsEva's linzagolix to reflect a daily cost of $25. He keeps a Buy rating on ObsEva shares.
08/22/18
PIPR
08/22/18
NO CHANGE
Target $130
PIPR
Overweight
AbbVie decision suggests positive Argenx data, says Piper Jaffray
AbbVie's (ABBV) decision to exercise an exclusive option to license Argenx's (ARGX) anti-GARP antibody, ARGX-115, suggests positive preclinical data, Piper Jaffray analyst Edward Tenthoff tells investors in a research note. The analyst looks for investigational new drug application filing plans this year. He reiterates an Overweight rating on shares of Argenx with a $130 price target.
08/29/18
HCWC
08/29/18
NO CHANGE
Target $44
HCWC
Buy
AbbVie study of elagolix reduces risk for ObsEva, says H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju believes AbbVie's (ABBV) long-term safety extension study of elagolix in women with uterine fibroids reduces risk for ObsEva (OBSV). The long-term efficacy for elagolix should bode well for future development of ObsEva's linzagolix in uterine fibroids, since both drugs are gonadotropin-releasing hormone receptor antagonists and have thus far shown comparable potency in clinical studies, Selvaraju tells investors in a research note. The analyst reiterates a Buy rating on ObsEva with a $44 price target.
09/10/18
BTIG
09/10/18
INITIATION
Target $32
BTIG
Buy
Voyager Therapeutics assumed with a Buy at BTIG
BTIG analyst Thomas Shrader assumed Voyager Therapeutics (VYGR) with a Buy rating and a price target of $32, saying the company is an "attractive investment" based on its lead product for late-stage Parkinson's Disease patients and its "robust" adeno-associated viral technology platform. The analyst expects Voyager to be well served in its upcoming gene therapy market share competition and also cites the company's "productive FDA meetings"and the start of of a phase 2 trial. Shrader further notes that Voyager Therapeutics' latest Abbvie (ABBV) deal is a "vote of confidence" for its program.

TODAY'S FREE FLY STORIES

BSVN

Bank7

$18.12

(0.00%)

04:52
10/15/18
10/15
04:52
10/15/18
04:52
Initiation
Bank7 initiated  »

Bank7 initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNLSY

Renault

$0.00

(0.00%)

04:49
10/15/18
10/15
04:49
10/15/18
04:49
Downgrade
Renault rating change  »

Renault downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

03:40
10/15/18
10/15
03:40
10/15/18
03:40
General news
FX Action: USD-CAD has settled in the lower 1.3000s »

FX Action: USD-CAD has…

03:15
10/15/18
10/15
03:15
10/15/18
03:15
General news
FX Update: The Yen has traded moderately firmer »

FX Update: The Yen has…

BAC

Bank of America

$28.42

0.07 (0.25%)

20:25
10/14/18
10/14
20:25
10/14/18
20:25
Earnings
Notable company reporting before Monday's open »

The notable company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 24

    Oct

JPM

JPMorgan

$106.88

-1.18 (-1.09%)

19:56
10/14/18
10/14
19:56
10/14/18
19:56
Periodicals
JPMorgan's Dimon cancels plans to attend Saudi investor event, Reuters says »

JP Morgan CEO Jamie Dimon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 21

    Oct

  • 24

    Oct

  • 26

    Feb

HRS

Harris

$154.88

0.61 (0.40%)

, LLL

L3 Technologies

$195.99

0.74 (0.38%)

19:15
10/14/18
10/14
19:15
10/14/18
19:15
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

HRS

Harris

$154.88

0.61 (0.40%)

LLL

L3 Technologies

$195.99

0.74 (0.38%)

ATVI

Activision Blizzard

$77.99

4.13 (5.59%)

SNE

Sony

$55.50

-0.01 (-0.02%)

MSFT

Microsoft

$109.54

3.63 (3.43%)

TSLA

Tesla

$259.11

6.93 (2.75%)

JPM

JPMorgan

$106.88

-1.18 (-1.09%)

WFC

Wells Fargo

$52.12

0.7 (1.36%)

BAC

Bank of America

$28.42

0.07 (0.25%)

SCHW

Charles Schwab

$49.02

0.89 (1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

  • 16

    Oct

  • 19

    Oct

  • 19

    Oct

  • 21

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 13

    Nov

  • 28

    Nov

  • 13

    Dec

  • 26

    Feb

  • 03

    Mar

  • 12

    Apr

  • 13

    Jul

  • 12

    Oct

AAPL

Apple

$222.10

7.61 (3.55%)

19:11
10/14/18
10/14
19:11
10/14/18
19:11
Periodicals
Apple buys music analytics startup Asaii, Axios reports »

Apple has acquired Asaii,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$8.65

-0.16 (-1.82%)

18:15
10/14/18
10/14
18:15
10/14/18
18:15
Periodicals
Ford chairman cancels visit to Saudi investor conference, Reuters reports »

Ford Motor Chairman Bill…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

HON

Honeywell

$156.15

2.45 (1.59%)

17:16
10/14/18
10/14
17:16
10/14/18
17:16
Hot Stocks
Honeywell business jet aviation forecast projects 7,700 new aircraft deliveries »

The business jet industry…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 19

    Oct

T

AT&T

$32.23

0.48 (1.51%)

, CMCSA

Comcast

$34.61

0.93 (2.76%)

16:41
10/14/18
10/14
16:41
10/14/18
16:41
Hot Stocks
Box Office Battle: 'Venom' wins domestic box office again with $35.7M »

Sony's (SNE)…

T

AT&T

$32.23

0.48 (1.51%)

CMCSA

Comcast

$34.61

0.93 (2.76%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$55.50

-0.01 (-0.02%)

FOX

21st Century Fox

$44.94

0.15 (0.33%)

FOXA

21st Century Fox

$45.36

0.23 (0.51%)

LGF.A

Lionsgate

$22.51

0.79 (3.64%)

DIS

Disney

$112.61

1.44 (1.30%)

VIAB

Viacom

$31.39

0.2 (0.64%)

VIA

Viacom

$34.46

-0.25 (-0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 24

    Oct

  • 06

    Nov

  • 12

    Nov

  • 13

    Nov

HRS

Harris

$154.88

0.61 (0.40%)

, LLL

L3 Technologies

$195.99

0.74 (0.38%)

16:33
10/14/18
10/14
16:33
10/14/18
16:33
Conference/Events
L3 Technologies and Harris to hold a joint conference call »

The companies hold a…

HRS

Harris

$154.88

0.61 (0.40%)

LLL

L3 Technologies

$195.99

0.74 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

ROK

Rockwell Automation

$172.89

2.3 (1.35%)

16:19
10/14/18
10/14
16:19
10/14/18
16:19
Hot Stocks
Harpak-ULMA, Rockwell Automation to deliver smart, connected packaging machines »

Harpak-ULMA announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATVI

Activision Blizzard

$77.99

4.13 (5.59%)

, SNE

Sony

$55.50

-0.01 (-0.02%)

16:16
10/14/18
10/14
16:16
10/14/18
16:16
Hot Stocks
New Call of Duty delivers biggest launch day one digital sales for Activision »

Call of Duty: Black Ops 4…

ATVI

Activision Blizzard

$77.99

4.13 (5.59%)

SNE

Sony

$55.50

-0.01 (-0.02%)

MSFT

Microsoft

$109.54

3.63 (3.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 21

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 13

    Nov

  • 28

    Nov

  • 03

    Mar

COL

Rockwell Collins

$134.20

-0.26 (-0.19%)

, ERJ

Embraer

$19.24

-0.095 (-0.49%)

16:11
10/14/18
10/14
16:11
10/14/18
16:11
Hot Stocks
Rockwell Collins' Pro Line Fusion selected for Embraer's Praetor 500/600 jets »

Rockwell Collins'…

COL

Rockwell Collins

$134.20

-0.26 (-0.19%)

ERJ

Embraer

$19.24

-0.095 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

HON

Honeywell

$156.15

2.45 (1.59%)

, ERJ

Embraer

$19.24

-0.095 (-0.49%)

16:06
10/14/18
10/14
16:06
10/14/18
16:06
Hot Stocks
Honeywell engines to power Embraer's latest executive aircraft models »

Honeywell (HON) engines…

HON

Honeywell

$156.15

2.45 (1.59%)

ERJ

Embraer

$19.24

-0.095 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 19

    Oct

GWRE

Guidewire

$88.77

1.63 (1.87%)

16:00
10/14/18
10/14
16:00
10/14/18
16:00
Hot Stocks
Guidewire announces 2018.2 release of P&C insurance industry platform »

Guidewire announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSC

Acquired by JPM

$0.00

(0.00%)

, GS

Goldman Sachs

$213.91

0.93 (0.44%)

13:14
10/14/18
10/14
13:14
10/14/18
13:14
Periodicals
Barclays to take on Goldman with new U.S. retail current account, FT reports »

Barclays (BCS) is…

BSC

Acquired by JPM

$0.00

(0.00%)

GS

Goldman Sachs

$213.91

0.93 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

LLL

L3 Technologies

$195.99

0.74 (0.38%)

12:48
10/14/18
10/14
12:48
10/14/18
12:48
Earnings
L3 Technologies raises FY18 adjusted EPS view to $10.20-$10.30 from $9.80-$10.00 »

FY18 consensus $10.05.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

LLL

L3 Technologies

$195.99

0.74 (0.38%)

12:42
10/14/18
10/14
12:42
10/14/18
12:42
Earnings
L3 Technologies reports preliminary Q3 adjusted EPS $2.85, consensus $2.41 »

Reports preliminary Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

HRS

Harris

$154.88

0.61 (0.40%)

12:28
10/14/18
10/14
12:28
10/14/18
12:28
Earnings
Harris raises FY19 cont ops EPS $7.80-$7.90, consensus $7.84 »

Sees FY19 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

HRS

Harris

$154.88

0.61 (0.40%)

12:24
10/14/18
10/14
12:24
10/14/18
12:24
Earnings
Harris reports Q1 adjusted EPS $1.78, consensus $1.71 »

Reports Q1 revenue $1.5B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

HRS

Harris

$154.88

0.61 (0.40%)

, LLL

L3 Technologies

$195.99

0.74 (0.38%)

12:18
10/14/18
10/14
12:18
10/14/18
12:18
Hot Stocks
Harris, L3 Technologies to combine in merger of equals »

Harris Corporation (HRS)…

HRS

Harris

$154.88

0.61 (0.40%)

LLL

L3 Technologies

$195.99

0.74 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

LOACU

Longevity Acquisition Corporation

$10.24

(0.00%)

12:11
10/14/18
10/14
12:11
10/14/18
12:11
Hot Stocks
Longevity Acquisition announces separate trading of ordinary shares, rights »

Longevity Acquisition…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRS

Harris

$154.88

0.61 (0.40%)

, LLL

L3 Technologies

$195.99

0.74 (0.38%)

08:10
10/14/18
10/14
08:10
10/14/18
08:10
Periodicals
Harris, L3 Technologies near agreement to merge, WSJ reports »

Harris Corporation (HRS)…

HRS

Harris

$154.88

0.61 (0.40%)

LLL

L3 Technologies

$195.99

0.74 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.